MECP2 and myelodysplastic syndrome: MECP2 is robustly down-regulated in both unaffected control and MDS lines treated with MECP2 ASO, confirming our qPCR results (Fig. 4B, Fig. 5A, and Supplementary Material, Fig. S5A).